Ad
related to: how to understand pat testing for prostate cancer- Case Studies
Review real case studies
with real patients.
- Sign Up for Updates
Sign up to receive the latest data,
case studies, and resources.
- Find an Imaging Site
Locate the nearest imaging site
or contact customer service.
- Contact Us
Contact our representatives
for product and reimbursement info.
- Case Studies
Search results
Results from the WOW.Com Content Network
The highest levels of acid phosphatase are found in metastasized prostate cancer. Diseases of the bone, such as Paget's disease or hyperparathyroidism , diseases of blood cells , such as sickle-cell disease or multiple myeloma or lysosomal storage diseases , such as Gaucher's disease , will show moderately increased levels.
A histopathologic diagnosis of prostate cancer is the discernment of whether there is a cancer in the prostate, as well as specifying any subdiagnosis of prostate cancer if possible. The histopathologic subdiagnosis of prostate cancer has implications for the possibility and methodology of any subsequent Gleason scoring . [ 1 ]
A PSMA scan is a nuclear medicine imaging technique used in the diagnosis and staging of prostate cancer. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand.
One vital tool in this quest to diagnose and treat this common cancer is prostate-specific antigen, or PSA, testing, which is a simple blood test offering valuable insights into prostate health.
The PSA test on its own is not currently recommended as a screening test for prostate cancer because, although a high level of PSA can be a sign of the disease, PSA levels can also be raised ...
As with most blood tests, false-negatives can happen, meaning results could come back negative when a cancer does exist — although Grail reports that negative cancer test results from Galleri ...
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
“Prostate Cancer UK’s new report makes it clear that this reluctance from my doctors was unfounded and outdated; prostate cancer diagnosis is safer and more effective now than it has ever been.
Ad
related to: how to understand pat testing for prostate cancer